You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Genetic Vectors

Showing 1 - 25 of 7,445
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ethnic Backgrounds on Facial Dysmorphic Features of Rare

Not yet recruiting
  • Rare Diseases
  • Take photo
  • (no location specified)
Jun 13, 2023

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

HIV Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452), gp160 MN/LAI-2, ALVAC(1)120(B,MN)GNP (vCP1433))

Completed
  • HIV Infections
  • ALVAC(2)120(B,MN)GNP (vCP1452)
  • +4 more
  • Birmingham, Alabama
  • +5 more
Oct 27, 2021

After Adoptive Transfer of Genetically Modified Cell Products

Recruiting
  • Relapsed Hematologic Malignancy
  • Refractory Hematologic Malignancy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Feb 6, 2023

    Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced

    Completed
    • Parkinson's Disease
    • Convection enhanced delivery/AAV2-GDNF
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    HIV, HIV Seronegativity Trial in United States (ALVAC-HIV MN120TMG (vCP205))

    Completed
    • HIV Infections
    • HIV Seronegativity
    • ALVAC-HIV MN120TMG (vCP205)
    • Birmingham, Alabama
    • +5 more
    Oct 28, 2021

    Hypertriglyceridemia, Familial Trial in Nanjing (GC304)

    Not yet recruiting
    • Hypertriglyceridemia, Familial
    • GC304
    • Nanjing, China
      Affiliated Jinling Hospital, Medical School, Nanjing University
    May 5, 2023

    Subjects Previously Enrolled in Poxviral Vector Gene Transfer

    Recruiting
    • Prostate Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 19, 2022

      Following Treatment With Fate Therapeutics' Engineered Cellular

      Terminated
      • Hematological Malignancy
      • Genetically engineered NK cells
      • Phoenix, Arizona
      • +4 more
      Aug 24, 2022

      Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Sham)

      Completed
      • Leber Hereditary Optic Neuropathy
      • GS010
      • Sham
      • Pasadena, California
      • +6 more
      Jul 25, 2022

      Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program Trial in Worldwide

      Recruiting
      • Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
      • Previously treated CAR-T patients
      • Phoenix, Arizona
      • +71 more
      Nov 14, 2022

      HIV Trial in United States (MN rgp120/HIV-1 and GNE8 rgp120/HIV-1, ALVAC-HIV MN120TMG (vCP205), ALVAC-RG Rabies Glycoprotein

      Completed
      • HIV Infections
      • MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
      • +2 more
      • Birmingham, Alabama
      • +5 more
      Oct 27, 2021

      Plasmid Inhibitors and Antimicrobial Drugs Against Clinical

      Not yet recruiting
      • Synergy Between Plasmid Inhibitors and Combined Antibiotics
        • (no location specified)
        Jun 27, 2023

        Genetics of Obesity in Chinese Youngs

        Recruiting
        • Obesity
        • Metabolic Syndrome
          • Shanghai, Shanghai, China
            Shanghai Jiao Tong University School of Medicine
          Apr 20, 2021

          Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

          Active, not recruiting
          • Retinitis Pigmentosa
          • +6 more
          • Gene Therapy Product-vMCO-010
          • Sham Injection
          • Beverly Hills, California
          • +6 more
          Jul 13, 2022

          Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber) Trial (GS010)

          Available
          • Leber Hereditary Optic Neuropathy (Optic, Atrophy, Hereditary, Leber)
          • GS010
          • (no location specified)
          Aug 2, 2021

          Allogeneic Gamma Delta (?d) CAR T Cells

          Enrolling by invitation
          • Lymphoma, Follicular
          • +5 more
          • ADI-001
          • Stanford, California
          • +4 more
          Jun 7, 2022

          Patients Who Received Gene-Modified Cell Therapy

          Enrolling by invitation
          • Long-term Follow-up
          • Gene-Modified Cell Therapy
          • Philadelphia, Pennsylvania
            Abramson Cancer Center Clinical Research Unit, University of Pen
          Jul 21, 2022

          Malignant Glioma, Glioblastoma Multiforme Trial in Ann Arbor (Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L)

          Completed
          • Malignant Glioma
          • Glioblastoma Multiforme
          • Dose Escalation of Ad-hCMV-TK and Ad-hCMV-Flt3L
          • Ann Arbor, Michigan
            University of Michigan Health System Department of Neurosurgery
          Aug 25, 2021

          Leber Hereditary Optic Neuropathy Trial in Worldwide (GS010, Placebo)

          Active, not recruiting
          • Leber Hereditary Optic Neuropathy
          • GS010
          • Placebo
          • Pasadena, California
          • +12 more
          Aug 2, 2022

          Wiskott-Aldrich Syndrome (WAS) Trial in Milan (OTL-103)

          Active, not recruiting
          • Wiskott-Aldrich Syndrome (WAS)
          • OTL-103
          • Milan, Italy
            Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
          Apr 21, 2022

          Lysosomal Storage Disease, Metachromatic Leukodystrophy Trial in Milan (OTL-200 Gene Therapy)

          Active, not recruiting
          • Lysosomal Storage Disease
          • Metachromatic Leukodystrophy
          • OTL-200 Gene Therapy
          • Milan, Italy
            Ospedale San Raffaele - Telethon Institute for Gene Therapy (OSR
          Nov 4, 2022

          Metachromatic Leukodystrophy, Adrenoleukodystrophy Trial in Shenzhen (transduced CD34+ hematopoietic stem cell)

          Recruiting
          • Metachromatic Leukodystrophy
          • Adrenoleukodystrophy
          • transduced CD34+ hematopoietic stem cell
          • Shenzhen, Guangdong, China
            Shenzhen Second People's Hospital, The First Affiliated Hospital
          May 25, 2022

          Gene Mutation-Related Cancer, Genetic Predisposition Trial (Genetic Information Assistant, Telegenetics with UVA genetic

          Not yet recruiting
          • Gene Mutation-Related Cancer
          • Genetic Predisposition
          • Genetic Information Assistant
          • Telegenetics with UVA genetic counselor
          • (no location specified)
          Oct 17, 2023

          Colonic Tumors, Colorectal Tumors Trial in Detroit, New York, Cincinnati (GRT-C901, GRT-R902, Atezolizumab)

          Recruiting
          • Colonic Neoplasms
          • Colorectal Neoplasms
          • Detroit, Michigan
          • +2 more
          Aug 1, 2022